| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Nov 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 84.98B | 85.86B | 83.38B | 80.36B | 74.52B | 73.13B |
| Gross Profit | 31.64B | 32.61B | 30.54B | 28.53B | 26.82B | 26.70B |
| EBITDA | 2.88B | 2.87B | 1.99B | 1.33B | 1.63B | 2.25B |
| Net Income | 805.00M | 618.00M | -163.00M | -1.17B | -274.40M | 194.00M |
Balance Sheet | ||||||
| Total Assets | 34.24B | 34.44B | 29.64B | 29.34B | 28.44B | 28.29B |
| Cash, Cash Equivalents and Short-Term Investments | 5.13B | 4.81B | 2.03B | 2.83B | 3.95B | 3.16B |
| Total Debt | 3.90B | 3.90B | 3.90B | 3.80B | 803.00M | 17.00M |
| Total Liabilities | 23.32B | 23.74B | 19.22B | 18.66B | 16.34B | 15.77B |
| Stockholders Equity | 10.91B | 10.70B | 10.42B | 10.68B | 12.10B | 12.52B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.69B | 36.00M | -2.44B | -288.00M | -664.00M |
| Operating Cash Flow | 0.00 | 4.39B | 1.89B | -899.00M | 906.00M | 1.17B |
| Investing Cash Flow | 0.00 | -2.17B | -2.51B | -2.11B | -1.54B | -2.02B |
| Financing Cash Flow | 0.00 | 386.00M | -173.00M | 2.72B | 519.00M | -272.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ¥666.58B | 22.09 | 7.58% | 2.58% | 6.52% | -31.67% | |
66 Neutral | ¥310.75B | 2.68 | 4.97% | 2.01% | 2.00% | -68.35% | |
63 Neutral | ¥229.20B | 17.32 | ― | 3.01% | 18.89% | -34.43% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
55 Neutral | ¥51.64B | -52.70 | ― | 0.51% | 2.90% | ― | |
50 Neutral | ¥55.18B | -3.92 | ― | 0.94% | 10.66% | -218.40% | |
49 Neutral | ¥4.99T | 82.87 | 2.27% | 0.52% | 4.92% | 1.25% |